Search by Drug Name or NDC
NDC 58809-0450-04 COZIMA 24 g/100g Details
COZIMA 24 g/100g
COZIMA is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is ZINC OXIDE.
Product Information
NDC | 58809-0450 |
---|---|
Product ID | 58809-450_d57d169f-3435-82eb-e053-2995a90a81bf |
Associated GPIs | 90971020003725 |
GCN Sequence Number | 080205 |
GCN Sequence Number Description | zinc oxide CREAM (G) 24 % TOPICAL |
HIC3 | L3A |
HIC3 Description | PROTECTIVES |
GCN | 46916 |
HICL Sequence Number | 002361 |
HICL Sequence Number Description | ZINC OXIDE |
Brand/Generic | Brand |
Proprietary Name | COZIMA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Zinc Oxide |
Product Type | HUMAN OTC DRUG |
Dosage Form | CREAM |
Route | TOPICAL |
Active Ingredient Strength | 24 |
Active Ingredient Units | g/100g |
Substance Name | ZINC OXIDE |
Labeler Name | GM Pharmaceuticals, INC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part347 |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 58809-0450-04 (58809045004)
NDC Package Code | 58809-450-04 |
---|---|
Billing NDC | 58809045004 |
Package | 113 g in 1 BOTTLE (58809-450-04) |
Marketing Start Date | 2018-10-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL ac1faa46-2e2a-4500-9d32-e51da7b2fe43 Details
SPL UNCLASSIFIED SECTION
Uses
Warnings
Directions
Other Information
Inactive Ingredients
acrylates/acrylamide copolymer, ceteareth-25, citronella oil, coconut oil, dimethicone, disodium EDTA, glycerin, isopropyl myristate, lemongrass oil, mineral oil, octyldodecanol, peg-20 methyl glucose sesquistearate, polysorbate 85, propylene glycol stearate , purified water, stearyl alcohol, tea tree oil
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
COZIMA
zinc oxide cream |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
|
Labeler - GM Pharmaceuticals, INC (793000860) |
Revised: 1/2022
Document Id: d57d169f-3435-82eb-e053-2995a90a81bf
Set id: ac1faa46-2e2a-4500-9d32-e51da7b2fe43
Version: 4
Effective Time: 20220113